Literature DB >> 6342070

Chemical nature, properties, location, and physiological and pathological variations of modified nucleosides in tRNAs.

G Dirheimer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6342070     DOI： 10.1007/978-3-642-81947-6_2

Source DB:  PubMed          Journal:  Recent Results Cancer Res        ISSN： 0080-0015


× No keyword cloud information.
  8 in total

Review 1.  Summary: the modified nucleosides of RNA.

Authors:  P A Limbach; P F Crain; J A McCloskey
Journal:  Nucleic Acids Res       Date:  1994-06-25       Impact factor: 16.971

2.  Enzymatic conversion of adenosine to inosine in the wobble position of yeast tRNAAsp: the dependence on the anticodon sequence.

Authors:  E Haumont; M Fournier; S de Henau; H Grosjean
Journal:  Nucleic Acids Res       Date:  1984-03-26       Impact factor: 16.971

3.  The primary structures of two arginine tRNAs (anticodons C-C-U and mcm5a2U-C-psi) and of glutamine tRNA (anticodon C-U-G) from bovine liver.

Authors:  G Keith
Journal:  Nucleic Acids Res       Date:  1984-03-12       Impact factor: 16.971

4.  Interaction of HIV-1 reverse transcriptase with a synthetic form of its replication primer, tRNA(Lys,3).

Authors:  C Barat; S F Le Grice; J L Darlix
Journal:  Nucleic Acids Res       Date:  1991-02-25       Impact factor: 16.971

5.  Posttranscriptional modification of tRNA in thermophilic archaea (Archaebacteria).

Authors:  C G Edmonds; P F Crain; R Gupta; T Hashizume; C H Hocart; J A Kowalak; S C Pomerantz; K O Stetter; J A McCloskey
Journal:  J Bacteriol       Date:  1991-05       Impact factor: 3.490

6.  Structure determination of a new fluorescent tricyclic nucleoside from archaebacterial tRNA.

Authors:  J A McCloskey; P F Crain; C G Edmonds; R Gupta; T Hashizume; D W Phillipson; K O Stetter
Journal:  Nucleic Acids Res       Date:  1987-01-26       Impact factor: 16.971

7.  Collision-induced dissociation of uracil and its derivatives.

Authors:  C C Nelson; J A McCloskey
Journal:  J Am Soc Mass Spectrom       Date:  1994-05       Impact factor: 3.109

8.  Urinary pseudouridine excretion in myelomatosis.

Authors:  S H Sørensen; D A Brown; E H Cooper; K A Kelly; I C MacLennan
Journal:  Br J Cancer       Date:  1985-12       Impact factor: 7.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.